Hims & Hers Health, Inc. (HIMS)

NYQ – Real vaqt narxi. Valyuta: USD

25.03

-4.11 (-14.10%)

Yopilishda: May 12, 2026, 4:00 PM EDT

24.77

-0.26 (-1.04%)

Bozor oldidan: May 13, 2026, 8:04 AM EDT

12.05.2026

Hims & Hers Health: The Real Story Begins

Hims & Hers Health raised FY2026 revenue guidance to $2.8-$3.0 billion despite reporting a heavily distorted quarterly EPS loss. More than 125,000 Wegovy shipments in six weeks suggest Novo conversion rates are materially outperforming bearish expectations. Gross margin fell to 65%, but adjusted gross margin exceeded 70% after excluding $33 million in restructuring charges.

12.05.2026

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?

Shares of telehealth provider Hims & Hers Health NYSE: HIMS sold off sharply following disappointing Q1 FY2026 financial results, with shares falling more than 12% in after-hours trading after the company reported on May 11.

12.05.2026

Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down

HIMS reports an adjusted loss and a revenue miss in first-quarter 2026 as gross margin decreases, but it lifts its full-year revenue outlook.

12.05.2026

Hims & Hers shares plummet on first quarter earnings miss

Hims & Hers (NYSE:HIMS) reported first quarter financial results that included a wider-than-expected loss and softer revenue performance, sending shares down nearly 14% to about $25 on Tuesday morning. For the quarter, the telehealth company posted a net loss of $92.1 million, or $0.40 loss per share, compared with a net profit of $49.5 million in the same period last year.

12.05.2026

Hims & Hers Drops After Earnings Miss & HIMS Options Trade

Marley Kayden breaks down Him & Hers (HIMS) after the company missed on both earnings and revenue. She explains how the end of the weight-loss drug shortage hurt their momentum, despite a rise in subscribers.

12.05.2026

JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story

Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer telehealth name following a messy first quarter.

12.05.2026

Tuesday's Morning Movers: HIMS, ASTS & ONON Down on Earnings

Diane King Hall talks about notable earnings movers as markets open lower. Hims & Hers (HIMS) fell after a surprise loss as U.S. sales decline.

Videolar

12.05.2026

Negative

Hims & Hers Drops After Earnings Miss & HIMS Options Trade

12.05.2026

Negative

Tuesday's Morning Movers: HIMS, ASTS & ONON Down on Earnings

12.05.2026

Negative

U.S.-Iran Ceasefire on "Life Support," HIMS & ASTS Earnings Sell-Off

09.03.2026

Positive

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
HIMS	Citigroup	Neutral	undefined >> $24	March 10th 2026
HIMS	BofA Securities	Neutral	undefined >> $23	March 10th 2026
HIMS	Needham	Buy	undefined >> $30	March 9th 2026
HIMS	BTIG Research	Neutral	undefined >> undefined	February 24th 2026
HIMS	Evercore ISI	In-line	undefined >> $33	January 12th 2026
HIMS	Barclays	Overweight	undefined >> $48	December 9th 2025
HIMS	KeyBanc Capital Markets	Sector Weight	undefined >> undefined	October 21st 2025
HIMS	Needham	Hold	undefined >> undefined	June 23rd 2025

Press-relizlar

11.05.2026

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2026. Moving forward, the Company plans to transition to an annual rather than quarterly shareholder letter and will continue to provide regular updates through a quarterly earnings call, earnings release, and supplemental materials. “2026 is a defining year for Hims &.

28.04.2026

Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company's 2026 annual shareholder meeting in June. Amoo-Gottfried is a seasoned marketing leader with decades of experience helping global transformative brands change how consumers think about their everyday lives. He served as Chief Marketing Officer at DoorDash and in leadership roles at.

08.04.2026

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

03.04.2026

Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach

SAN FRANCISCO, April 03, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is actively investigating data privacy claims arising from the Hims & Hers, Inc. data breach. On February 5, 2026, Hims & Hers, Inc. discovered a data breach affecting its computer network.

Hims & Hers Health, Inc. (HIMS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health: The Real Story Begins

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?

Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down

Hims & Hers shares plummet on first quarter earnings miss

Hims & Hers Drops After Earnings Miss & HIMS Options Trade

JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story